These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

370 related articles for article (PubMed ID: 33522967)

  • 1. Neuroligin-1 in brain and CSF of neurodegenerative disorders: investigation for synaptic biomarkers.
    Camporesi E; Lashley T; Gobom J; Lantero-Rodriguez J; Hansson O; Zetterberg H; Blennow K; Becker B
    Acta Neuropathol Commun; 2021 Feb; 9(1):19. PubMed ID: 33522967
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tau protein profiling in tauopathies: a human brain study.
    Lantero-Rodriguez J; Camporesi E; Montoliu-Gaya L; Gobom J; Piotrowska D; Olsson M; Burmann IM; Becker B; Brinkmalm A; Burmann BM; Perkinton M; Ashton NJ; Fox NC; Lashley T; Zetterberg H; Blennow K; Brinkmalm G
    Mol Neurodegener; 2024 Jul; 19(1):54. PubMed ID: 39026372
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Selective tau tyrosine nitration in non-AD tauopathies.
    Reyes JF; Geula C; Vana L; Binder LI
    Acta Neuropathol; 2012 Jan; 123(1):119-32. PubMed ID: 22057784
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Distinct phosphorylation profiles of tau in brains of patients with different tauopathies.
    Samimi N; Sharma G; Kimura T; Matsubara T; Huo A; Chiba K; Saito Y; Murayama S; Akatsu H; Hashizume Y; Hasegawa M; Farjam M; Shahpasand K; Ando K; Hisanaga SI
    Neurobiol Aging; 2021 Dec; 108():72-79. PubMed ID: 34536819
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Different immunoreactivities of the microtubule-binding region of tau and its molecular basis in brains from patients with Alzheimer's disease, Pick's disease, progressive supranuclear palsy and corticobasal degeneration.
    Arai T; Ikeda K; Akiyama H; Tsuchiya K; Iritani S; Ishiguro K; Yagishita S; Oda T; Odawara T; Iseki E
    Acta Neuropathol; 2003 May; 105(5):489-98. PubMed ID: 12677450
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glycogen synthase kinase-3 is associated with neuronal and glial hyperphosphorylated tau deposits in Alzheimer's disease, Pick's disease, progressive supranuclear palsy and corticobasal degeneration.
    Ferrer I; Barrachina M; Puig B
    Acta Neuropathol; 2002 Dec; 104(6):583-91. PubMed ID: 12410379
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detection of Alzheimer Disease (AD)-Specific Tau Pathology in AD and NonAD Tauopathies by Immunohistochemistry With Novel Conformation-Selective Tau Antibodies.
    Gibbons GS; Banks RA; Kim B; Changolkar L; Riddle DM; Leight SN; Irwin DJ; Trojanowski JQ; Lee VMY
    J Neuropathol Exp Neurol; 2018 Mar; 77(3):216-228. PubMed ID: 29415231
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phosphorylated c-MYC expression in Alzheimer disease, Pick's disease, progressive supranuclear palsy and corticobasal degeneration.
    Ferrer I; Blanco R; Carmona M; Puig B
    Neuropathol Appl Neurobiol; 2001 Oct; 27(5):343-51. PubMed ID: 11679086
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SCRN1: A cerebrospinal fluid biomarker correlating with tau in Alzheimer's disease.
    Weiner S; Sauer M; Brinkmalm G; Constantinescu J; Constantinescu R; Gomes BF; Becker B; Nellgård B; Dalla K; Galasko D; Zetterberg H; Blennow K; Gobom J
    Alzheimers Dement; 2023 Oct; 19(10):4609-4618. PubMed ID: 36946611
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quantification of the trans-synaptic partners neurexin-neuroligin in CSF of neurodegenerative diseases by parallel reaction monitoring mass spectrometry.
    Camporesi E; Nilsson J; Vrillon A; Cognat E; Hourregue C; Zetterberg H; Blennow K; Becker B; Brinkmalm A; Paquet C; Brinkmalm G
    EBioMedicine; 2022 Jan; 75():103793. PubMed ID: 34990894
    [TBL] [Abstract][Full Text] [Related]  

  • 11. AMPK is abnormally activated in tangle- and pre-tangle-bearing neurons in Alzheimer's disease and other tauopathies.
    Vingtdeux V; Davies P; Dickson DW; Marambaud P
    Acta Neuropathol; 2011 Mar; 121(3):337-49. PubMed ID: 20957377
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased pro-nerve growth factor and decreased brain-derived neurotrophic factor in non-Alzheimer's disease tauopathies.
    Belrose JC; Masoudi R; Michalski B; Fahnestock M
    Neurobiol Aging; 2014 Apr; 35(4):926-33. PubMed ID: 24112788
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ultrasensitive and selective detection of 3-repeat tau seeding activity in Pick disease brain and cerebrospinal fluid.
    Saijo E; Ghetti B; Zanusso G; Oblak A; Furman JL; Diamond MI; Kraus A; Caughey B
    Acta Neuropathol; 2017 May; 133(5):751-765. PubMed ID: 28293793
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phosphorylation and cleavage of tau in non-AD tauopathies.
    Guillozet-Bongaarts AL; Glajch KE; Libson EG; Cahill ME; Bigio E; Berry RW; Binder LI
    Acta Neuropathol; 2007 May; 113(5):513-20. PubMed ID: 17357802
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuroligin-1 is altered in the hippocampus of Alzheimer's disease patients and mouse models, and modulates the toxicity of amyloid-beta oligomers.
    Dufort-Gervais J; Provost C; Charbonneau L; Norris CM; Calon F; Mongrain V; Brouillette J
    Sci Rep; 2020 Apr; 10(1):6956. PubMed ID: 32332783
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Divergent CSF τ alterations in two common tauopathies: Alzheimer's disease and progressive supranuclear palsy.
    Wagshal D; Sankaranarayanan S; Guss V; Hall T; Berisha F; Lobach I; Karydas A; Voltarelli L; Scherling C; Heuer H; Tartaglia MC; Miller Z; Coppola G; Ahlijanian M; Soares H; Kramer JH; Rabinovici GD; Rosen HJ; Miller BL; Meredith J; Boxer AL
    J Neurol Neurosurg Psychiatry; 2015 Mar; 86(3):244-50. PubMed ID: 24899730
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structure of NFT: Biochemical Approach.
    Hasegawa M
    Adv Exp Med Biol; 2019; 1184():23-34. PubMed ID: 32096025
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Decreased beta-amyloid peptide42 in cerebrospinal fluid of patients with progressive supranuclear palsy and corticobasal degeneration.
    Noguchi M; Yoshita M; Matsumoto Y; Ono K; Iwasa K; Yamada M
    J Neurol Sci; 2005 Oct; 237(1-2):61-5. PubMed ID: 15992827
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Patterns of hippocampal tau pathology differentiate neurodegenerative dementias.
    Milenkovic I; Petrov T; Kovacs GG
    Dement Geriatr Cogn Disord; 2014; 38(5-6):375-88. PubMed ID: 25195847
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel tau filament fold in corticobasal degeneration.
    Zhang W; Tarutani A; Newell KL; Murzin AG; Matsubara T; Falcon B; Vidal R; Garringer HJ; Shi Y; Ikeuchi T; Murayama S; Ghetti B; Hasegawa M; Goedert M; Scheres SHW
    Nature; 2020 Apr; 580(7802):283-287. PubMed ID: 32050258
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.